4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001213900-22-005787
CEO and CFO bought 5,000 shares at $19.59 ($97,950)
From the SEC's structured data for this filing
Trades in this filing
Patel Snehal · CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-04 | Purchase : show line 1 in the form | +5,000 | $19.59 | $97,950 | 1,199,429 | D |
| Open-market purchases · 5,000 sh · avg $19.59 · $97,950 | ||||||
Loading xslF345X03/ownership.xml…